Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, ...

The decision is part of a wider board overhaul amid pressure from shareholder Oaktree Capital Management, which owns a 7.3% stake in Indivior, which has repeatedly called for the drugmaker to ...

Additionally, Rigel Pharmaceuticals has appointed Dr. Mark W. Frohlich, an experienced oncologist, to its Board of Directors to support its hematology and oncology pipeline. H.C. Wainwright ...

Trump sons’ appointment to Dominari Holdings’ advisory board sent its stock soaring—but records of the board’s existence before their involvement are scarce.

Evoke Pharma (EVOK) announced the appointment of Greg Pyszczymuka to its Board of Directors, effective February 20, 2025. This marks the second ...

Mr. Tomohiro Tohyama and Mr. Kuniaki Kaga to retire from the Board of Directors Chris Cargill, President & CEO of Nxera Pharma, said: “We welcome the nominations of Naoko and Nicola as new ...

This marks the second board member appointment by Nantahala Capital ... is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue growth.